Showing results (1231-1240 of 1,420) with videos related to

Sort By:
Pageof 142
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|November 1, 2019
[A phenotypic and genetic study on β-propeller protein-associated neurodegeneration]W H Li, Q Chen, H Wang, et al.
Physical Review Letters|June 1, 2004
Precise mass measurement of 68Se, a waiting-point nuclide along the rp processJ A Clark, G Savard, K S Sharma, et al.
JDR Clinical and Translational Research|August 12, 2025
Arginine Dentifrices and Childhood Caries Prevention: A Randomized Clinical TrialW Yin, Z Zhou, R-Z Huang, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 24, 2025
Types of stent retrievers used in mechanical thrombectomy for acute ischaemic stroke: A scoping reviewJane Song, Kevin Z Zhou, Davor Pavlin-Premrl, et al.
Nature Communications|December 23, 2015
Ultra-low-frequency wave-driven diffusion of radiation belt relativistic electronsZhenpeng Su, Hui Zhu, Fuliang Xiao, et al.
Polish Journal of Veterinary Sciences|October 2, 2020
Characterization of serum adiponectin and leptin in healthy perinatal dairy cows or cows with ketosis, and their effectson ketosis involved indicesL Shen, B Qian, J Xiao, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|April 26, 2013
Prevalence of cardiovascular disease and risk factors in the Chinese population with impaired glucose regulation: the 2007-2008 China national diabetes and metabolic disorders studyZ Yang, X Xing, J Xiao, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2001
Synthesis of thiophene-2-carboxamidines containing 2-aminothiazoles and their biological evaluation as urokinase inhibitorsK J Wilson, C R Illig, N Subasinghe, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|July 20, 2022
[Preconception reproductive health and birth outcome cohort in Chongqing: the cohort profile]Q Chen, W Z Zhou, N Y Zhou, et al.
ESMO Open|March 28, 2022
Treatment-related adverse events as predictive biomarkers of efficacy in patients with advanced neuroendocrine tumors treated with surufatinib: results from two phase III studiesJ Li, Y Cheng, C Bai, et al.
Pageof 142